4-aminoquinoline-based hybrids (Leidos)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug Name4-aminoquinoline-based hybrids (Leidos)

Drug Alias Name4-aminoquinoline-based hybrids (SAIC-Frederick)4-aminoquinoline-triazine hybrids (SAIC-Frederick)4-aminoquinoline-C5-curcuminoids hybrids (SAIC-Frederick)LSC-12SM-332 +[6]

ClassificationSmall molecules

Mechanisms of ActionApoptosis stimulants

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesLeidos Biomedical Research Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesLeidos Biomedical Research Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A